From the Departments of Pulmonary Diseases.
Public Health, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye.
South Med J. 2023 Dec;116(12):957-961. doi: 10.14423/SMJ.0000000000001626.
Impulse oscillometry (IOS) is a type of oscillation technique that measures the input impedance (Z) of the respiratory system and can be used to detect pathological changes in the small airways at an early stage. Although coronavirus disease 2019 (COVID-19) affects the vascular and parenchymal structures in the lung, chronic postinfection coughs also may be attributed to small airway pathologies. Our research aimed to use IOS for the assessment of the presence of small airway resistance (R) in patients who have had COVID-19.
Thirty-eight patients with past COVID-19 infections and without any presence or medical treatment of an airway disease who presented to the post-COVID outpatient clinic with coughing symptoms were included in the study. The control group consisted of 17 patients with no past COVID-19 infection and without an airway disease. IOS and spirometry were performed twice in the case group, at 3 and 6 months after COVID-19.
The mean age of the case group was 44.7 ± 12.3 years, whereas the mean age of the control group was 49.4 ± 11.8 years. The case group consisted of 38 patients, whereas 17 patients constituted the control group. No statistically significant difference was found between the two groups in the first and second test measurements, performed 3 months apart ( > 0.05).
The fact that there was no difference between respiratory system impedance, airway resistance, and spirometry values between groups with and without past COVID-19 infections supported the hypothesis that small airways were not affected 3 months after COVID-19.
脉冲震荡法(IOS)是一种振荡技术,可测量呼吸系统的输入阻抗(Z),并可用于早期检测小气道的病理变化。虽然 2019 年冠状病毒病(COVID-19)会影响肺部的血管和实质结构,但慢性感染后咳嗽也可能归因于小气道病变。我们的研究旨在使用 IOS 评估 COVID-19 患者小气道阻力(R)的存在情况。
本研究纳入了 38 例过去有 COVID-19 感染且无气道疾病存在或治疗史、因咳嗽症状就诊于 COVID-19 门诊的患者。对照组由 17 例无过去 COVID-19 感染且无气道疾病的患者组成。在 COVID-19 后 3 个月和 6 个月,对病例组进行了两次 IOS 和肺量测定。
病例组的平均年龄为 44.7±12.3 岁,而对照组的平均年龄为 49.4±11.8 岁。病例组由 38 例患者组成,对照组由 17 例患者组成。两组在相隔 3 个月进行的第一次和第二次测试测量中,没有发现统计学差异(>0.05)。
在过去有 COVID-19 感染和无 COVID-19 感染的两组之间,呼吸系统阻抗、气道阻力和肺量测定值没有差异,这一事实支持了小气道在 COVID-19 后 3 个月不受影响的假设。